Filing 2024 Q4 - Restatement compared to 2024 Q3 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Paul Singer
President
West Palm Beach, Florida
4/25/2025
In the original filing made on February 14, 2025, the box for Confidential Treatment Requested on the Form 13F Summary Page was inadvertently checked. However, no information was omitted from the original filing as a result thereof. This amendment number 1 restates and corrects the original filing with the box for Confidential Treatment Requested now unchecked.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.